We are live on ! Find out more
ONXX

ONYX PHARMACEUTICALS INC
ONXX

Delisted

ONXX was delisted on the 30th of September, 2013.

Back to rankings

0 hedge funds and large institutions have $0 invested in ONYX PHARMACEUTICALS INC in 2013 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 257 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 258 → 0 (-258)

100% less funds holding in top 10

Funds holding in top 10: 46 → 0 (-46)

100% less capital invested

Capital invested by funds: $7.38B → $0 (-$7.38B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 257

Holders
–
Holders Change
-258
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-46
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
257
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$512M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$421M
3
DKCM
Davidson Kempner Capital Management
New York
-$393M
4
HI
HBK Investments
Texas
-$339M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$259M
Name Holding Trade Value Shares
Change 		Change in
Stake
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
– -$512M -4,109,042 Closed
Vanguard Group
2
Vanguard Group
Pennsylvania
– -$421M -3,377,132 Closed
DKCM
3
Davidson Kempner Capital Management
New York
– -$393M -3,150,321 Closed
HI
4
HBK Investments
Texas
– -$339M -2,719,365 Closed
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
– -$259M -2,077,236 Closed
FCM
6
Farallon Capital Management
California
– -$252M -2,020,000 Closed
ACPU
7
Arrowgrass Capital Partners (US)
Delaware
– -$246M -1,976,636 Closed
BIT
8
BlackRock Institutional Trust
California
– -$220M -1,766,433 Closed
Barclays
9
Barclays
United Kingdom
– -$193M -1,553,089 Closed
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
– -$173M -1,388,375 Closed
WCMNY
11
Westchester Capital Management (New York)
New York
– -$170M -1,366,168 Closed
BFA
12
BlackRock Fund Advisors
California
– -$169M -1,358,224 Closed
State Street
13
State Street
Massachusetts
– -$150M -1,201,964 Closed
Wellington Management Group
14
Wellington Management Group
Massachusetts
– -$145M -1,161,739 Closed
Bank of America
15
Bank of America
North Carolina
– -$126M -1,007,392 Closed
Citigroup
16
Citigroup
New York
– -$123M -986,042 Closed
OAM
17
Oxford Asset Management
United Kingdom
– -$118M -950,000 Closed
CPM
18
Chesapeake Partners Management
Maryland
– -$93.9M -753,019 Closed
TS
19
Twin Securities
New York
– -$93.3M -748,948 Closed
PA
20
Pinnacle Associates
New York
– -$90.6M -726,893 Closed
Norges Bank
21
Norges Bank
Norway
– -$89.5M -717,694 Closed
GI
22
GAMCO Investors
Connecticut
– -$80.4M -644,979 Closed
HT
23
HAP Trading
New York
– -$77.6M -622,007 Closed
Fidelity Investments
24
Fidelity Investments
Massachusetts
– -$75.5M -605,257 Closed
GF
25
Gabelli Funds
New York
– -$74.9M -600,500 Closed
1
2 3 4 5

ONXX Hedge Fund Activity: Q4 2013 in Review

0 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in ONYX PHARMACEUTICALS INC (ONXX) for Q4 2013, worth a combined $0 — down 100% from $7.38B a quarter earlier.

Sellers outnumbered buyers: 257 funds closed out of ONXX and 0 opened new positions — a net loss of 257 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Adage Capital Partners, exiting entirely with an estimated $512M sold.

  • 0 institutional investors held ONYX PHARMACEUTICALS INC (ONXX) as of Q4 2013, down from 258 in Q3 2013.
  • Funds reported $0 of ONYX PHARMACEUTICALS INC stock for Q4 2013, down 100% quarter-over-quarter.
  • 0 funds opened new ONYX PHARMACEUTICALS INC positions in Q4 2013 and 257 closed out, a net change of -257 holders.
  • The largest ONYX PHARMACEUTICALS INC seller in Q4 2013 was Adage Capital Partners, an estimated $512M sold.

Based on aggregated 13F filings for Q4 2013.